Intel's new CEO, Lip-Bu Tan, is driving efficiency, innovation, and potential mergers to spark a stock surge. See why we are ...

Full Year 2024 Results Key Financial Results Revenue: €98.7m (down 2.7% from FY 2023).

UK£1.03m (loss narrowed by 23% from 1H 2024). UK£0.005 loss per share (improved from UK£0.008 loss in 1H 2024). It is worth noting though that we have found 5 warning signs for SkinBioTherapeutics (1 ...